Medtronic plc (MDT)

Market Cap	99.21B
Revenue (ttm)	32.36B
Net Income (ttm)	3.68B
Shares Out	1.28B
EPS (ttm)	2.76
PE Ratio	28.03
Forward PE	14.47
Dividend	$2.80 (3.62%)
Ex-Dividend Date	Jun 28, 2024

Volume	4,977,962
Open	76.85
Previous Close	77.12
Day's Range	76.51 - 77.50
52-Week Range	68.84 - 91.00
Beta	0.84
Analysts	Hold
Price Target	93.00 (+20.2%)
Earnings Date	Aug 20, 2024

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: NYSE
• Ticker Symbol: MDT

Financial Performance

In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.

Analyst Forecast

According to 12 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $93.0, which is an increase of 20.20% from the latest price.

Price Target

$93.0

(20.20% upside)

Analyst Consensus: Hold